Literature DB >> 12462338

Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients.

Bernd Schröppel1, Michael Fischereder, Marvin Lin, Brad Marder, Tom Schiano, Bernhard K Krämer, Barbara Murphy.   

Abstract

Chemokines and their receptors play a major role in the inflammatory and immune responses that mediate allograft outcome. The production of some chemokines varies among individuals and these variations may be determined by genetic polymorphisms, most commonly within the regulatory region of the gene. We investigated whether the functional polymorphisms of the chemokines RANTES, MCP-1 and chemokine receptor CCR5 are associated with the incidence of acute rejection and long-term liver graft survival. Two hundred nine liver transplant recipients were genotyped using polymerase chain reaction sequence-specific primers for the following polymorphisms: RANTES-28, MCP-1 -2518, and CCR5-59029. There was no association with any of the three genotypes and the incidence of acute rejection episodes. In addition, no association of RANTES-28, MCP-1 -2518, or CCR5 -59029 variants with long-term liver graft survival was found. In conclusion, variants of RANTES-28, MCP-1 -2518, and CCR5-59029 neither influenced the incidence of acute rejection nor affected long-term allograft survival upon liver transplantation in the context of this analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462338     DOI: 10.1023/a:1020612500935

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

1.  RANTES in the postoperative course after liver transplantation.

Authors:  M Schenk; A Zipfel; C Schulz; H D Becker; R Viebahn
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

2.  Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants.

Authors:  S Goddard; A Williams; C Morland; S Qin; R Gladue; S G Hubscher; D H Adams
Journal:  Transplantation       Date:  2001-12-27       Impact factor: 4.939

3.  Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.

Authors:  C Szalai; J Duba; Z Prohászka; T Szabó; B Nagy; L Horváth; A Császár
Journal:  Atherosclerosis       Date:  2001-09       Impact factor: 5.162

Review 4.  Is HLA matching beneficial in liver transplantation?

Authors:  S B Moore
Journal:  Liver Transpl       Date:  2001-09       Impact factor: 5.799

5.  Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4.

Authors:  B Shieh; Y E Liau; P S Hsieh; Y P Yan; S T Wang; C Li
Journal:  Int Immunol       Date:  2000-09       Impact factor: 4.823

6.  Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection.

Authors:  G Grandaliano; L Gesualdo; E Ranieri; R Monno; G Stallone; F P Schena
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

7.  Early application of Met-RANTES ameliorates chronic allograft nephropathy.

Authors:  Erwei Song; Hequn Zou; Yousheng Yao; Amanda Proudfoot; Balazs Antus; Shanying Liu; Lutz Jens; Uwe Heemann
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

8.  Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation.

Authors:  Reza Abdi; Tran Thi Bich Huong; Alfredo Sahagun-Ruiz; Philip M Murphy; Barry M Brenner; Edgar L Milford; David H McDermott
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

9.  The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation.

Authors:  Bernd Schröppel; Michael Fischereder; Rami Ashkar; Marvin Lin; Bernhard K Krämer; Brad Mardera; Tom Schiano; Barbara Murphy
Journal:  Am J Transplant       Date:  2002-08       Impact factor: 8.086

10.  CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

Authors:  D H McDermott; P A Zimmerman; F Guignard; C A Kleeberger; S F Leitman; P M Murphy
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

View more
  1 in total

1.  Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease.

Authors:  Minal Borkar; Gaurav Tripathi; Raj Kumar Sharma; Satya Narayan Sankhwar; Suraksha Agrawal
Journal:  Inflamm Res       Date:  2010-12-04       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.